Bharat Biotech's COVID-19 vaccine Covaxin has gained approval for emergency use in children aged 12 to 18, the Indian company said on Twitter.
Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi//File Photo
Dec 25 - Bharat Biotech's COVID-19 vaccine Covaxin has gained approval for emergency use in children aged 12 to 18, the Indian company said onThe tweet came minutes after Indian Prime Minister Narendra Modi said in an address to the nation that 15-18 year olds would start receiving COVID-19 vaccinations from Jan. 3.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
How can I protect a child too young for a COVID-19 vaccine?Children younger than 5 can’t get COVID-19 vaccines in the U.S. yet, but there are steps you can take to protect them from infection over the holidays.
続きを読む »
IMF extends emergency funding by 18 months due to CovidThe International Monetary Fund said Thursday it will extend its flexible access to emergency funding for an additional 18 months to help nations severely impacted by the Covid-19 pandemic.
続きを読む »
Trump again publicly defends COVID-19 vaccines, but slams mandatesDonald Trump publicly defended the COVID-19 vaccines and their efficacy, but decried mask and vaccine mandates, in an interview posted online on Tuesday.
続きを読む »
New COVID-19 vaccine rule catches many Kenyans by surpriseKenya's sudden decision to demand proof of vaccination to access public places and transport was met by a combination of bemusement, dismissal and the occasional spot of enforcement on Thursday as people headed home for Christmas.
続きを読む »
Trump Tells Candace Owens That Covid-19 Vaccines Work: ‘One Of The Greatest Achievements Of Mankind’And earlier in the week, both Trump and Bill O' Reilly said that they got the Covid-19 booster shots yet then got booed.
続きを読む »
Japan health panel approves Merck's oral COVID-19 treatmentA Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck & Co Inc , part of Prime Minister Fumio Kishida's plan to roll out new treatments by year-end as concerns rise about the Omicron variant.
続きを読む »